OrbiMed creates debt facility for pharmaceutical firm

OrbiMed Advisors led the completion of a $200 million debt facility for Harmony Biosciences, a firm that develops treatment options for people living with rare diseases.

The . . .

Continue Reading With a Free Trial

Unlock this article instantly, along with the rest of our premium content, newsletters and mandate charts.

Already a subscriber? Log in.

Related Articles

Back to top button

Get our daily news digest
in your inbox

Our FREE mailing list brings you daily alts intel.

Thank you for subscribing.

Something went wrong.